Protecting new ideas and inventions in nanomedicine with patents
Protecting new ideas and inventions in nanomedicine with patents
复制标题
DOI：
10.1016/j.nano.2005.03.009
复制
发表时间：
2005-06-01
影响因子：
5.4
通讯作者：
Wei, Chiming
中科院分区：
文献类型：
--
作者：
Bawa, Raj;Bawa, S. R.;Wei, Chiming
新的模式正在缩小我们的世界。微小的是在和专利是必不可少的成功在纳米医学。事实上，专利已经在塑造这个新生且快速发展的领域。在过去的十年中，一群与纳米医学有关的专利申请已经到达美国专利商标局（PTO）。随着公司开发产品和工艺，并开始为其发明寻求商业应用，确保有效和可辩护的专利保护对其长期生存至关重要。随着我们进入医学或纳米医学的“黄金时代”，在未来十年，随着该领域的成熟和承诺的突破不断增加，专利将产生许可收入，为交易和合并提供杠杆，并减少侵权的可能性。由于纳米生物技术和纳米医学相关产品的开发是极其研究密集型的，如果没有美国专利提供的市场排他性，这些产品的开发及其在市场上的商业可行性将受到显着阻碍。在这篇文章中，我们强调了与纳米医学产品专利有关的关键问题。“专利勘探者”正在纳米医学领域进行的“纳米专利土地掠夺”的影响正在被审查，因为初创公司和公司在这些关键的早期竞争锁定广泛的专利。由于纳米医学是多学科的，专利申请提供了独特的机会，并提出了许多挑战。虽然专利正在更积极地寻求和更有力地执行，但整个专利系统正在受到更大的审查和压力，PTO继续努力评估与纳米医学相关的专利申请。(C)2005年爱思唯尔公司All rights reserved.
New paradigms are shrinking our world. Tiny is in and patents are essential for success in nanomedicine. In fact, patents are already shaping this nascent and rapidly evolving field. For the past decade a swarm of patent applications pertaining to nanomedicine has been arriving at the US Patent and Trademark Office (PTO). As companies develop products and processes and begin to seek commercial applications for their inventions, securing valid and defensible patent protection will be vital to their long-term survival. As we enter the "golden era" of medicine, or nanomedicine, in the next decade with the field maturing and the promised breakthroughs accruing, patents will generate licensing revenue, provide leverage in deals and mergers, and reduce the likelihood of infringement. Because development of nanobiotechnology- and nanomedicine-related products is extremely research intensive, without the market exclusivity offered by a US patent, development of these products and their commercial viability in the marketplace will be significantly hampered. In this article, we highlight critical issues relating to patenting nanomedicine products. Effects of the "nanopatent land grab" that is underway in nanomedicine by "patent prospectors" are examined as startups and corporations compete to lock up broad patents in these critical early days. Because nanomedicine is multidisciplinary, patenting presents unique opportunities and poses numerous challenges. Although patents are being sought more actively and enforced more vigorously, the entire patent system is under greater scrutiny and strain, with the PTO continuing to struggle with evaluating nanomedicine-related patent applications. (C) 2005 Elsevier Inc. All rights reserved.